États-Unis · Plateformes & données · MarketBeat

Dr. Reddy's Laboratories Ltd (NYSE:RDY) Stock Has Consensus Target Price of $492.90

Publié par MarketBeat · États-Unis il y a 1 h

Dr. Reddy's Laboratories Ltd (NYSE:RDY - Get Free Report) has earned an average recommendation of "Hold" from the five analysts that are presently covering the firm, Marketbeat…

Lire l'article complet sur MarketBeat Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.marketbeat.com)

Dr. Reddy's Laboratories Ltd (NYSE:RDY) Stock Has Consensus Target Price of $492.90

À lire aussi

Down 17%, Is Meta a Buy on the Dip?

Johnson & Johnson reports response rate for head, neck cancer treatment

Goldman lists 3 factors that support long commodities positions

‘She’s living the dream’: My stepmother said I can buy my childhood home for $850,000. Is she taking advantage of me?

Samsung’s Galaxy Fit 4 could undercut Fitbit by $120

TeraWulf CEO Paul Prager Turns Elon Musk’s ‘Stranded Compute’ Warning Into A Buying Pitch

Dr. Reddy's Laboratories Ltd (NYSE:RDY) Stock Has Consensus Target Price of $492.90

Partager

À lire aussi

Down 17%, Is Meta a Buy on the Dip?

Johnson & Johnson reports response rate for head, neck cancer treatment

Goldman lists 3 factors that support long commodities positions

‘She’s living the dream’: My stepmother said I can buy my childhood home for $850,000. Is she taking advantage of me?

Samsung’s Galaxy Fit 4 could undercut Fitbit by $120

TeraWulf CEO Paul Prager Turns Elon Musk’s ‘Stranded Compute’ Warning Into A Buying Pitch